Search Results - "immunogenicity"

Seasonal influenza vaccines: Variability of immune responses to B lineage viruses by Matthew S. Miller, Emanuele Montomoli, Eyal Leshem, Michael Schotsaert, Thomas Weinke, Nevena Vicic, Deborah Rudin

Connect to this object online.

Comparative analysis of physicochemical properties, bioequivalence, safety and tolerability of the first domestic semaglutide by A. S. Ametov, I. E. Shokhin, E. A. Rogozhina, T. G. Bodrova, M. E. Nevretdinova, P. A. Bely, K. Ya. Zaslavskaya, V. S. Scherbakova, D. V. Kurkin, K. N. Koryanova, E. S. Mishchenko, E. Yu. Kesova, E. D. Kozlov, E. S. Samoshkina, D. N. Andreev, Yu. G. Kazaishvili, S. M. Noskov, L. A. Balykova

Connect to this object online.

Immune responses to AAV vectors, from bench to bedside by Hildegard Buning

DOAB: download the publication
DOAB: description of the publication

Open-label phase I clinical trial of Ad5-EBOV in Africans in China by Lihua Wu, Zhe Zhang, Hainv Gao, Yuhua Li, Lihua Hou, Hangping Yao, Shipo Wu, Jian Liu, Ling Wang, You Zhai, Huilin Ou, Meihua Lin, Xiaoxin Wu, Jingjing Liu, Guanjing Lang, Qian Xin, Guolan Wu, Li Luo, Pei Liu, Jianzhong Shentu, Nanping Wu, Jifang Sheng, Yunqing Qiu, Wei Chen, Lanjuan Li

Connect to this object online.

Coadministration of seasonal influenza and COVID-19 vaccines: A systematic review of clinical studies by Cécile Janssen, Anne Mosnier, Gaëtan Gavazzi, Behazine Combadière, Pascal Crépey, Jacques Gaillat, Odile Launay, Elisabeth Botelho-Nevers

Connect to this object online.

Evidence synthesis and pooled analysis of vaccine effectiveness for COVID-19 mRNA vaccine BNT162b2 as a heterologous booster after inactivated SARS-CoV-2 virus vaccines by Moe H. Kyaw, Julia Spinardi, Ling Zhang, Helen May Lin Oh, Amit Srivastava

Connect to this object online.

NAD+ biosynthesis metabolism predicts prognosis and indicates immune microenvironment for breast cancer by Yuting Yang, Ze Wang, Mengqi He, Lihong Diao, Biyue Yu, Dong Li, Dong Li

Connect to this object online.

Harnessing adenovirus in cancer immunotherapy: evoking cellular immunity and targeting delivery in cell-specific manner by Miao Zeng, Wei Zhang, Yisheng Li, Li Yu

Connect to this object online.

Strategy "treat to target" for patients with psoriasis. Relevant issues to biological therapy persistence by A. L. Bakulev

Connect to this object online.

Clinical experience with the inactivated hepatitis A vaccine, Avaxim 80U Pediatric by Catherine Bravo, Larissa Mege, Claire Vigne, Yael Thollot

Connect to this object online.

TLR Agonists as Vaccine Adjuvants Targeting Cancer and Infectious Diseases by Marina Luchner, Sören Reinke, Anita Milicic

Connect to this object online.

Accelerating HIV vaccine development using non-human primate models by Mohammad Arif Rahman, Marjorie Robert-Guroff

Connect to this object online.

Emerging experience with meningococcal serogroup B protein vaccines by Daniela Toneatto, Mariagrazia Pizza, Vega Masignani, Rino Rappuoli

Connect to this object online.

Induction of adaptive immune response by self-aggregating peptides by Jesus Zepeda-Cervantes, Luis Vaca

Connect to this object online.

Evolution of the understanding of psoriasis and therapeutic approaches used to manage such patients. BCD-085 is the first Russian genetically-engineered biological preparation for... by A. L. Bakulev

Connect to this object online.

Evidence for a 10-year TBE vaccine booster interval: an evaluation of current data by Jörg Schelling, Suzanne Einmahl, Ralph Torgler, Carsten Schade Larsen

Connect to this object online.

Tracking trends in COVID-19 vaccines based on 47 different vaccines: A bibliometric review by Zhongbin Tao, Caihua Xu, Luying Cheng, Mingyue Zhang, Jianguo Xu, Qingyong Zheng, Jun Zhang, Wenjun Lu, Caiyi Sheng, Jinhui Tian

Connect to this object online.

Plant-derived nanovesicles: Further exploration of biomedical function and application potential by Aixue Li, Dan Li, Yongwei Gu, Rongmei Liu, Xiaomeng Tang, Yunan Zhao, Fu Qi, Jifu Wei, Jiyong Liu

Connect to this object online.

Immune Checkpoint Inhibitors for Vaccine Improvements: Current Status and New Approaches by Alexander Batista-Duharte, Fakhri Hassouneh, Pablo Alvarez-Heredia, Alejandra Pera, Rafael Solana

Connect to this object online.

Decreased performance of live attenuated, oral rotavirus vaccines in low-income settings: causes and contributing factors by Daniel E. Velasquez, Umesh Parashar, Baoming Jiang

Connect to this object online.